Yahoo Web Search

Search results

    • J&J to Sell Remaining Stake in Kenvue Spinoff

      Morningstar· 7 hours ago

      Johnson & Johnson plans to unload its remaining 9.5% stake in Kenvue in a public offering set about a year after it started splitting off the Tylenol and Benadryl maker. Kenvue said Monday that ...